Vaughan Nelson Investment Management L.P. increased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 67.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 733,505 shares of the company’s stock after purchasing an additional 296,625 shares during the quarter. Vaughan Nelson Investment Management L.P. owned approximately 0.79% of Acadia Healthcare worth $49,541,000 as of its most recent filing with the SEC.
Several other large investors have also recently added to or reduced their stakes in the stock. Tranquility Partners LLC raised its stake in shares of Acadia Healthcare by 5.3% during the 4th quarter. Tranquility Partners LLC now owns 3,395 shares of the company’s stock worth $264,000 after purchasing an additional 170 shares in the last quarter. New York State Teachers Retirement System grew its position in Acadia Healthcare by 0.3% in the first quarter. New York State Teachers Retirement System now owns 76,054 shares of the company’s stock worth $6,025,000 after acquiring an additional 200 shares in the last quarter. Blue Trust Inc. increased its stake in shares of Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after purchasing an additional 248 shares during the last quarter. Quent Capital LLC lifted its stake in shares of Acadia Healthcare by 8.1% in the 1st quarter. Quent Capital LLC now owns 3,784 shares of the company’s stock valued at $300,000 after purchasing an additional 284 shares during the last quarter. Finally, Retirement Systems of Alabama boosted its holdings in Acadia Healthcare by 0.3% in the first quarter. Retirement Systems of Alabama now owns 115,799 shares of the company’s stock worth $9,174,000 after purchasing an additional 303 shares in the last quarter.
Wall Street Analysts Forecast Growth
ACHC has been the subject of a number of analyst reports. Bank of America reduced their price target on Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Mizuho lowered their price target on Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a report on Friday, May 3rd. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Tuesday, May 21st. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Wednesday, May 22nd. Finally, Barclays decreased their price target on shares of Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating for the company in a report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $87.44.
Acadia Healthcare Stock Performance
ACHC stock traded up $0.34 during trading on Friday, reaching $74.47. 701,691 shares of the stock were exchanged, compared to its average volume of 790,196. Acadia Healthcare Company, Inc. has a twelve month low of $62.04 and a twelve month high of $87.77. The company has a current ratio of 1.18, a quick ratio of 1.27 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $6.91 billion, a P/E ratio of -531.93, a price-to-earnings-growth ratio of 2.21 and a beta of 1.32. The stock has a 50 day simple moving average of $68.08 and a 200-day simple moving average of $72.77.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. The company had revenue of $796.00 million during the quarter, compared to the consensus estimate of $784.38 million. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The company’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the company earned $0.92 EPS. As a group, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.51 earnings per share for the current year.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories
- Five stocks we like better than Acadia Healthcare
- What is a Dividend King?
- This Small Cap Wealth Management Stock Could Provide Big Returns
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.